Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviz Technologies (INVZ) Cash & Equivalents (2019 - 2025)

Historic Cash & Equivalents for Innoviz Technologies (INVZ) over the last 7 years, with Q3 2025 value amounting to $7.9 million.

  • Innoviz Technologies' Cash & Equivalents fell 7172.71% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year decrease of 7172.71%. This contributed to the annual value of $25.4 million for FY2024, which is 343.19% down from last year.
  • Innoviz Technologies' Cash & Equivalents amounted to $7.9 million in Q3 2025, which was down 7172.71% from $13.5 million recorded in Q2 2025.
  • Innoviz Technologies' Cash & Equivalents' 5-year high stood at $199.1 million during Q1 2021, with a 5-year trough of $7.9 million in Q3 2025.
  • Over the past 5 years, Innoviz Technologies' median Cash & Equivalents value was $27.9 million (recorded in 2024), while the average stood at $53.0 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 9013.72% in 2022, then soared by 47741.39% in 2023.
  • Over the past 5 years, Innoviz Technologies' Cash & Equivalents (Quarter) stood at $23.6 million in 2021, then skyrocketed by 135.69% to $55.7 million in 2022, then tumbled by 52.83% to $26.3 million in 2023, then decreased by 3.49% to $25.4 million in 2024, then plummeted by 68.85% to $7.9 million in 2025.
  • Its Cash & Equivalents was $7.9 million in Q3 2025, compared to $13.5 million in Q2 2025 and $13.4 million in Q1 2025.